Abstract #2762

Response of degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy

Basetti Madhu¹, Greg Shaw¹, David Neal¹, and John R Griffiths¹

¹Molecular Imaging (MRI & MRS), Cancer Research UK Cambridge Institute, Cambridge, United Kingdom

Absolute concentrations of metabolites were measured in samples of Benign Prostate Hypertrophy (BPH) and high grade prostate cancer tissues from intact and castrate patients (Degarelix treated). Lactate, alanine, choline compounds concentrations were significantly elevated in high-grade prostate cancer biopsies when compared to BPH samples. Castration resulted in the significant decrease of lactate and t-choline concentrations in high grade prostate cancer biopsies. The reduced metabolite concentrations of lactate and t-choline observed in this study due to Degarelix shows that there is a potential application of in vivo ¹H MRS to monitor non-invasively the effects of castration in prostate cancer .

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.